Regencell Bioscience Holdings Limited
NASDAQ: RGC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yat-Gai Au
- Employees
- 12
- Headquarters
- Causeway Bay, Hong Kong SAR China
- IPO year
- 2021
- Market cap
- $5.9B
- Website
- https://www.regencellbioscience.com
Loading RGC…
Loading profile data…Frequently asked questions about RGC
What does Regencell Bioscience Holdings Limited (RGC) do?
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on co...
Where does RGC trade?
Regencell Bioscience Holdings Limited (RGC) trades on the NASDAQ Capital Market.
What sector is RGC in?
Regencell Bioscience Holdings Limited (RGC) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Regencell Bioscience Holdings Limited?
Yat-Gai Au is the chief executive officer of Regencell Bioscience Holdings Limited (RGC).
Where is Regencell Bioscience Holdings Limited headquartered?
Regencell Bioscience Holdings Limited is headquartered in Hong Kong SAR China.
Does RGC pay a dividend?
Regencell Bioscience Holdings Limited (RGC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RGC go public?
Regencell Bioscience Holdings Limited (RGC) completed its initial public offering in 2021.